Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Siemens Healthineers Liver Fibrosis Test Gets FDA Breakthrough Device Designation

Nov 08, 2018
|
staff reporter

NEW YORK (360Dx) – Siemens Healthineers said today that the US Food and Drug Administration has granted Breakthrough Device designation for its Advia Centaur Enhanced Liver Fibrosis (ELF) test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  2. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  3. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

  4. BARDA Awards $684K to Luminex for Enhanced COVID-19 Multiplex Antibody Test

  5. BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.